版本:
中国

BRIEF-Pfizer to have exclusive rights to distribute, commercialize CRESEMBA in Europe

June 14 Pfizer Inc:

* Pfizer receives exclusive commercialization rights in Europe for CRESEMBA, a novel treatment for potentially life-threatening fungal infections among immunocompromised patients

* Pfizer will have exclusive rights to distribute and commercialize CRESEMBA in Europe, including Austria, France, Germany, Italy and UK

* Pfizer will be responsible for additional CRESEMBA launches, predominantly in Europe, which are expected throughout 2017 and 2018​

* Basilea will remain marketing authorization holder for CRESEMBA in European Union Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐